國立高雄大學圖資館 |

Language: English

Back

Living with chronic diseasemeasuring...

Johns, Nutjaree.

Living with chronic diseasemeasuring important patient-reported outcomes /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Living with chronic diseaseby Paul Kamudoni, Nutjaree Johns, Sam Salek.
Reminder of title:	measuring important patient-reported outcomes /
Author:	Kamudoni, Paul.
other author:	Johns, Nutjaree.
Published:	Singapore :Springer Singapore :2018.
Description:	xii, 165 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Outcome assessment (Medical care)
Online resource:	https://doi.org/10.1007/978-981-10-8414-0
ISBN:	9789811084140$q(electronic bk.)

Living with chronic diseasemeasuring important patient-reported outcomes /
Kamudoni, Paul.

Living with chronic diseasemeasuring important patient-reported outcomes /[electronic resource] :by Paul Kamudoni, Nutjaree Johns, Sam Salek. - Singapore :Springer Singapore :2018. - xii, 165 p. :ill. (some col.), digital ;24 cm.

1. Overview -- 2. Approaches to the Development and Use of PROs: A Unified Framework -- 3. An Illustration of the New PRO Measure Development Roadmap Using an Example from Skin Disease -- 4. Determination of Fitness for Purpose: Content Verification by Patients and Experts -- 5. Conventional Methods Meeting Modern Techniques: Factor Analysis Versus Rasch Analysis -- 6. Assessing the Performance of PROs Against Expectation: Psychometric Calibration -- 7. Integrating Patient Reported Outcomes in Clinical Trials, Routine Clinical Practice and Medicines Development Programmes.

This book serves as a roadmap for the development and application of patient-reported outcome (PRO) measures, supporting beginners through to experts, as a practical guide. To elucidate on key concepts in the book, examples from clinical research in hyperhidrosis and health-related quality of life and medicines clinical development context, are used. Health-related quality of life represents one of the most commonly measured PROs in both routine clinical practice and research. The book demonstrates the importance of PROs to patients with chronic disease and how such outcomes can assist clinicians in managing patients and monitoring their response to treatment in terms of both symptoms and impacts. This book will benefit readers as a single-source practical guide on the development of modern PRO measures and may also serve as a blueprint for the conceptualization and planning of evidence generation related to PROs in various settings. Ideas and suggestions on how to navigate recent developments shaping the field of PRO measurement are also offered. Dr Paul Kamudoni (PhD MSc.) is a Scientific Associate Director in the Global Evidence and Value Development - R&D department at Merck KgaA in Darmstadt (Germany) where he leads the Centre of Excellence for Patient Reported Outcomes. Dr Kamudoni trained as a Pharmacoeconomist and a Clinical Outcome Measurement Scientist at Cardiff University. In his day to day work, he is involved in the development and validation of PRO measures, and the design and integration of PRO endpoints in clinical trials and other types of studies. He maintains an active research interest in methodological issues in the integration of electronic health records with prospective PRO assessments, and the application of item response theory in PRO measurement among others. Dr Nutjaree Pratheepawanit Johns (PhD PharmD) is an Associate Professor at the Faculty of Pharmaceutical Sciences, and melatonin research group, Khon Kaen University, Thailand. She has held a number of academic positions both in Thailand and abroad, including a fellowship at the Western Institutional Review Board (WIRB) (Olympia, WA, USA) Dr Johns has an expertise in cancer care and quality of life (QoL) research and collaborates with several cancer centres in Northeastern Thailand. She has developed and tested a number of PRO measures including cross-cultural adaptation into the Thai language. Dr Johns is also a principal investigator in many clinical trials investigating the effects of disease or interventions on QoL of cancer patients. She has been a recipient of several prestigious awards including Scholarship for Developing Country, International Society for Quality of Life Research and the Doyle Prize: Postgraduate section, Palliative Medicine Journal. Professor Sam Salek (PhD RPh FFPM FRPS MCMS FESCP) is Professor of Pharmacoepidemiology at the University of Hertfordshire, Hatfield, visiting Professor at the Estate of Hessen, Germany, and Director of the Institute for Medicines Development, Cardiff, UK. Professor Salek's research focuses mainly on four areas: development and application of PRO measures; drug safety evaluation and pharmacovigilance; pharmacoeconomics and economic evaluation of healthcare; and pharmaceutical regulation & medicines development in the mature and emerging markets. He has published 22 books and 600+ journal articles and abstracts. Professor Salek is a member of five Editorial Boards and an active member of several societies.

ISBN: 9789811084140$q(electronic bk.)

Standard No.: 10.1007/978-981-10-8414-0doiSubjects--Topical Terms:

203295
Outcome assessment (Medical care)

LC Class. No.: R853.O87 / K368 2018

Dewey Class. No.: 362.1

Living with chronic diseasemeasuring important patient-reported outcomes /
LDR:05130nmm a2200337 a 4500 001 544060
003 DE-He213
005 20190304170312.0
006 m d
007 cr nn 008maaau
008 190430s2018 si s 0 eng d
020 $a 9789811084140$q(electronic bk.)
020 $a 9789811084133$q(paper)
024 7 $a 10.1007/978-981-10-8414-0 $2 doi
035 $a 978-981-10-8414-0
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.O87 $b K368 2018
072 7 $a MBNH $2 bicssc
072 7 $a MED078000 $2 bisacsh
072 7 $a MBNH $2 thema
072 7 $a MBN $2 thema
082 0 4 $a 362.1 $2 23
090 $a R853.O87 $b K15 2018
100 1 $a Kamudoni, Paul. $3 822546
245 1 0 $a Living with chronic disease $h [electronic resource] : $b measuring important patient-reported outcomes / $c by Paul Kamudoni, Nutjaree Johns, Sam Salek.
260 $a Singapore : $b Springer Singapore : $b Imprint: Adis, $c 2018.
300 $a xii, 165 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a 1. Overview -- 2. Approaches to the Development and Use of PROs: A Unified Framework -- 3. An Illustration of the New PRO Measure Development Roadmap Using an Example from Skin Disease -- 4. Determination of Fitness for Purpose: Content Verification by Patients and Experts -- 5. Conventional Methods Meeting Modern Techniques: Factor Analysis Versus Rasch Analysis -- 6. Assessing the Performance of PROs Against Expectation: Psychometric Calibration -- 7. Integrating Patient Reported Outcomes in Clinical Trials, Routine Clinical Practice and Medicines Development Programmes.
520 $a This book serves as a roadmap for the development and application of patient-reported outcome (PRO) measures, supporting beginners through to experts, as a practical guide. To elucidate on key concepts in the book, examples from clinical research in hyperhidrosis and health-related quality of life and medicines clinical development context, are used. Health-related quality of life represents one of the most commonly measured PROs in both routine clinical practice and research. The book demonstrates the importance of PROs to patients with chronic disease and how such outcomes can assist clinicians in managing patients and monitoring their response to treatment in terms of both symptoms and impacts. This book will benefit readers as a single-source practical guide on the development of modern PRO measures and may also serve as a blueprint for the conceptualization and planning of evidence generation related to PROs in various settings. Ideas and suggestions on how to navigate recent developments shaping the field of PRO measurement are also offered. Dr Paul Kamudoni (PhD MSc.) is a Scientific Associate Director in the Global Evidence and Value Development - R&D department at Merck KgaA in Darmstadt (Germany) where he leads the Centre of Excellence for Patient Reported Outcomes. Dr Kamudoni trained as a Pharmacoeconomist and a Clinical Outcome Measurement Scientist at Cardiff University. In his day to day work, he is involved in the development and validation of PRO measures, and the design and integration of PRO endpoints in clinical trials and other types of studies. He maintains an active research interest in methodological issues in the integration of electronic health records with prospective PRO assessments, and the application of item response theory in PRO measurement among others. Dr Nutjaree Pratheepawanit Johns (PhD PharmD) is an Associate Professor at the Faculty of Pharmaceutical Sciences, and melatonin research group, Khon Kaen University, Thailand. She has held a number of academic positions both in Thailand and abroad, including a fellowship at the Western Institutional Review Board (WIRB) (Olympia, WA, USA) Dr Johns has an expertise in cancer care and quality of life (QoL) research and collaborates with several cancer centres in Northeastern Thailand. She has developed and tested a number of PRO measures including cross-cultural adaptation into the Thai language. Dr Johns is also a principal investigator in many clinical trials investigating the effects of disease or interventions on QoL of cancer patients. She has been a recipient of several prestigious awards including Scholarship for Developing Country, International Society for Quality of Life Research and the Doyle Prize: Postgraduate section, Palliative Medicine Journal. Professor Sam Salek (PhD RPh FFPM FRPS MCMS FESCP) is Professor of Pharmacoepidemiology at the University of Hertfordshire, Hatfield, visiting Professor at the Estate of Hessen, Germany, and Director of the Institute for Medicines Development, Cardiff, UK. Professor Salek's research focuses mainly on four areas: development and application of PRO measures; drug safety evaluation and pharmacovigilance; pharmacoeconomics and economic evaluation of healthcare; and pharmaceutical regulation & medicines development in the mature and emerging markets. He has published 22 books and 600+ journal articles and abstracts. Professor Salek is a member of five Editorial Boards and an active member of several societies.
650 0 $a Outcome assessment (Medical care) $3 203295
650 0 $a Chronically ill. $3 611464
650 0 $a Quality of life. $3 208442
650 1 4 $a Quality of Life Research. $3 274757
700 1 $a Johns, Nutjaree. $3 822547
700 1 $a Salek, Sam. $3 719855
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-10-8414-0
950 $a Medicine (Springer-11650)